Dr. Flora Peyvandi, under the auspices of the International Society of Thrombosis and Haemostasis, has spearheaded the development of an international network of care providers and national representatives to work together to discuss the prevalence, clinical manifestations, and need for coordinated and consistent data collection. The hope of this international community is to better identify the number of affected individuals throughout the world, define the clinical manifestations and sequelae associated with these disorders, create a network of individuals who care for these patients that are able to share diagnostic and treatment expertise, and provide potential centers where specific products once developed may be utilized in clinical trials. Since 1996 the RBDD Group have been collecting information and developing international collaborations across the RBDs network, becoming an International reference point. In the last ten years more than 400 patients with RBDs from a variety of countries were investigated. The continuing collaboration with different international centres will allow to further extend the knowledge of RBDs and give a platform to focus and develop further diagnostic and therapeutic research activity.

International Rare Bleeding Disorders Database [Dataset] / F. Peyvandi, R. Palla, M. Menegatti, I. Garagiola, S.M. Siboni, P.M. Mannucci, M. Spreafico, L. Tagliabue, S. Lavoretano, A. Cairo. - Milan, 2005 May 01.

International Rare Bleeding Disorders Database

F. Peyvandi
Primo
;
R. Palla
Secondo
;
M. Menegatti;I. Garagiola;S.M. Siboni;P.M. Mannucci;M. Spreafico;L. Tagliabue;S. Lavoretano
Penultimo
;
2005-05-01

Abstract

Dr. Flora Peyvandi, under the auspices of the International Society of Thrombosis and Haemostasis, has spearheaded the development of an international network of care providers and national representatives to work together to discuss the prevalence, clinical manifestations, and need for coordinated and consistent data collection. The hope of this international community is to better identify the number of affected individuals throughout the world, define the clinical manifestations and sequelae associated with these disorders, create a network of individuals who care for these patients that are able to share diagnostic and treatment expertise, and provide potential centers where specific products once developed may be utilized in clinical trials. Since 1996 the RBDD Group have been collecting information and developing international collaborations across the RBDs network, becoming an International reference point. In the last ten years more than 400 patients with RBDs from a variety of countries were investigated. The continuing collaboration with different international centres will allow to further extend the knowledge of RBDs and give a platform to focus and develop further diagnostic and therapeutic research activity.
rare disease ; bleeding disorder ; database
Settore MED/09 - Medicina Interna
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/33444
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact